 | Roivant Sciences Ltd. | |||
| NMS : ROIV || Location: United Kingdom | ||||
$10.880.0 (0.0%) |
0.87 M | 10.88 - 11.02 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 45.129 M |
| March 28, 2024 | 30.925 M |
| March 15, 2024 | 31.571 M |
| Feb. 29, 2024 | 27.692 M |
| Feb. 15, 2024 | 28.770 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.33 | -0.30 | 8.09% |
| 09/30/2023 | -0.31 | -0.40 | -27.11% |
| 06/30/2023 | -0.30 | -0.38 | -25.16% |
| 03/31/2023 | -0.37 | -0.20 | 45.73% |
| 12/31/2022 | -0.39 | -0.49 | -24.27% |
ROIV Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 805.846M | Shares Float | 421.643M |
| Short Float | 45.129M | Market Cap | 8767.60M |
| Institution ownership | 62.18% | Insider ownership | 20.623% |
| Earnings Date | Cash Per Share | ? | |
| Trailing EPS | 5.27 | Forward EPS | -1.33 |